Detail

Keywords

Pancreatectomy; Pancreatic Cancer; Pancreatic Diseases

Research group(s)

• Pancreatic surgery
  Head: Martin Schindl
  Research Area: Body composition and inflammation in pancreatic neoplasms.
  Members:
  Elisabeth S. Gruber
  Klaus Sahora
  Gerd Jomrich
  Jakob Mühlbacher
  Ulla Klaiber
• Pancreatic Cancer Unit
  Head: Martin Schindl
  Research Area: Diagnostic and treatment of pancreatic cancer and pancreatitis Intraductal papillary mucinous neoplasms Prehabilitation program before surgery
  Members:
  Elisabeth S. Gruber
  Klaus Sahora
  Ulla Klaiber
  Martin Schindl

Selected publications

1. Hackert, T.*, Klaiber, U.* et al. (2023) ‘Portal Vein Resection in Pancreatic Cancer Surgery: Risk of Thrombosis and Radicality Determine Survival’, Annals of Surgery, 277(6), pp. e1291–e1298. Available at: https://doi.org/10.1097/sla.0000000000005444. *Contributed equall.
2. Hank, T.*, Klaiber U.* et al. (2023) ‘Oncological Outcome of Conversion Surgery After Preoperative Chemotherapy for Metastatic Pancreatic Cancer’, Annals of Surgery, 277(5), pp. e1089–e1098. Available at: https://doi.org/10.1097/sla.0000000000005481. *Contributed equall.
3. Klaiber, U. et al. (2021) ‘Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer’, Annals of Surgery, 273(1), pp. 154–162. Available at: https://doi.org/10.1097/sla.0000000000003270.
4. Klaiber, U. et al. (2020) ‘Randomized Trial of Pylorus-Preserving vs. Pylorus-Resecting Pancreatoduodenectomy: Long-Term Morbidity and Quality of Life’, Journal of Gastrointestinal Surgery, 24(2), pp. 341–352. Available at: https://doi.org/10.1007/s11605-018-04102-y.
5. van Roessel, S. et al. (2020) ‘Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment’, JAMA Oncology, 6(11), p. 1733. Available at: https://doi.org/10.1001/jamaoncol.2020.3537.